Furthermore, overexpression of hepatocyte growth factor receptor (MET) is correlated with cisplatin and EGFR-targeted therapies resistance as well as with poor prognosis for HNSCC patients [18]. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.